Wang Gang, Jing Mengyuan, Xi Huaze, Lei Feng, Ren Wei, Zhou Junlin
Department of Radiology, First Hospital of Lanzhou University, Lanzhou, China.
Key Laboratory of Medical Imaging of Gansu Province, Lanzhou, China.
Quant Imaging Med Surg. 2024 Jan 3;14(1):503-513. doi: 10.21037/qims-23-951. Epub 2024 Jan 2.
In patients without coronary artery disease (CAD), few studies have evaluated the association between mean pericoronary adipose tissue attenuation (PCAT) and patient-based demographic factors, for example, age or sex. Therefore, the purpose of this study is to investigate the association between PCAT and various demographic factors in patients without CAD.
In this case-control study, the 806 patients who underwent coronary computed tomography angiography and were not diagnosed with CAD between July 2020 and July 2022 were retrospectively enrolled. Their PCAT values of the proximal right coronary artery were measured automatically. Patients without CAD were stratified according to sex, body mass index (BMI), and age, and the relationship between PCAT and different clinical characteristics was explored using Fisher's exact test or Chi-squared test and independent -tests or Wilcoxon Mann-Whitney tests.
Compared to non-smoking women [-88.00 (-95.00, -81.00) HU], women who smoked [-84.00 (-94.00, -78.00) HU, P=0.037] had higher PCAT values and a positive correlation with PCAT (rs=0.101, P=0.036). Compared to non-hypertensive patients with BMI ≥24.91 kg/m [-87.00 (-95.00, -81.00) HU], hypertensive patients with BMI ≥24.91 kg/m [-84.00 (-92.00, -78.00) HU, P=0.004] had higher PCAT values, and a positive correlation with PCAT (rs=0.144, P=0.004). In a subgroup of patients without CAD stratified by sex, BMI, and age, PCAT values were all higher in patients with dyslipidemia (women, men, BMI ≥24.91 kg/m, BMI <24.91 kg/m, age ≥55 years, and age <55 years: -82.00, -82.00, -81.50, -82.00, -81.00 and -83.50 HU, respectively) than in those without dyslipidemia (-89.00, -89.00, -89.00, -90.00, -90.00 and -88.00 HU, respectively; all P<0.001) and showed a positive relationship (rs=0.328, 0.339, 0.342, 0.326, 0.367, and 0.298, respectively; all P<0.001).
Higher PCAT attenuation values were observed in patients with dyslipidemia, smoking women, and hypertensive patients with BMI ≥24.91 kg/m, suggesting that PCAT values can be used to detect patients at high risk for future events with CAD even if they do not currently have atherosclerosis.
在无冠状动脉疾病(CAD)的患者中,很少有研究评估平均冠状动脉周围脂肪组织衰减(PCAT)与基于患者的人口统计学因素(如年龄或性别)之间的关联。因此,本研究的目的是调查无CAD患者中PCAT与各种人口统计学因素之间的关联。
在这项病例对照研究中,回顾性纳入了2020年7月至2022年7月期间接受冠状动脉计算机断层扫描血管造影且未被诊断为CAD的806例患者。自动测量其右冠状动脉近端的PCAT值。无CAD的患者根据性别、体重指数(BMI)和年龄进行分层,并使用Fisher精确检验或卡方检验以及独立样本t检验或Wilcoxon Mann-Whitney检验探讨PCAT与不同临床特征之间的关系。
与不吸烟女性[-88.00(-95.00,-81.00)HU]相比,吸烟女性[-84.00(-94.00,-78.00)HU,P = 0.037]的PCAT值更高,且与PCAT呈正相关(rs = 0.101,P = 0.036)。与BMI≥24.91 kg/m的非高血压患者[-87.00(-95.00,-81.00)HU]相比,BMI≥24.91 kg/m的高血压患者[-84.00(-92.00,-78.00)HU,P = 0.004]的PCAT值更高,且与PCAT呈正相关(rs = 0.144,P = 0.004)。在按性别、BMI和年龄分层的无CAD患者亚组中,血脂异常患者(女性、男性、BMI≥24.91 kg/m、BMI<24.91 kg/m、年龄≥55岁和年龄<55岁时的PCAT值分别为-82.00、-82.00、-81.50、-82.00、-81.00和-83.50 HU)的PCAT值均高于无血脂异常患者(分别为-89.00、-89.00、-89.00、-90.00、-90.00和-88.00 HU;所有P<0.001),并呈正相关(rs分别为0.328、0.339、0.342、0.326、0.367和0.298;所有P<0.001)。
在血脂异常患者、吸烟女性以及BMI≥24.91 kg/m的高血压患者中观察到较高的PCAT衰减值,这表明即使目前没有动脉粥样硬化,PCAT值也可用于检测未来发生CAD事件的高危患者。